Clinical Data Statistically significant mean reduction in PEC score at two hours compared to placebo following a single dose of 180 mcg (p<0.0001), with rapid and durable reductions in PEC score maintained for 4 to 6 hours
Approximately 90% of patients met response criteria at 180 mcg with a reduction in PEC score (≥40%)Results from secondary analyses were consistent with results observed for the primary endpoint and statistically significant for calming as measured by ACES at two hours compared to placebo following a single dose of 180 mcg (p<0.0001)Well-tolerated with no serious or severe adverse events across the entire dose range